Ralf Wiedemuth

DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy

Katrin Töpfer, Marc Cartellieri, Susanne Michen et al. · The Journal of Immunology · 2015 · 249 citations

Life Sciences, Immunology, Oncology +16

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo

Sandy Hendruschk, Ralf Wiedemuth, Achim Aigner et al. · Neuro-Oncology · 2011 · 69 citations · Full text

Life Sciences, Oncology, Pharmacology +13

Overcoming Concealment Effects of Targeting Moieties in the PEG Corona: Controlled Permeable Polymersomes Decorated with Folate‐Antennae for Selective Targeting of Tumor Cells

Mohamed A. Yassin, Dietmar Appelhans, Ralf Wiedemuth et al. · Small · 2014 · 67 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells

Marina Clemente Conde, Susanne Michen, Ralf Wiedemuth et al. · BMC Cancer · 2017 · 56 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the <i>IDH1</i> Mutation Status

Ortrud Uckermann, Tareq A. Juratli, Roberta Galli et al. · Clinical Cancer Research · 2017 · 36 citations

Natural Sciences, Biochemistry, Oncology +17